Difference between revisions of "Part:BBa K2718011"

(Activity test)
(Purification)
 
(17 intermediate revisions by 2 users not shown)
Line 6: Line 6:
  
  
HmaS is used in the metabolic pathway shown in figure 1 to produce benzyl alcohol.  
+
HmaS is the first enzyme in the metabolic pathway shown in figure 1 used to produce benzaldehyde and benzyl alcohol.  
HmaS catalyzes the oxidative decarboxylation of phenylpyruvate to produce (S)Mandelate.  
+
HmaS catalyzes the oxidative decarboxylation of phenylpyruvate to produce(S)Mandelate.  
  
  
 
https://static.igem.org/mediawiki/2018/2/2a/T--Aix-Marseille--BenzylAlcohol_pathway.png
 
https://static.igem.org/mediawiki/2018/2/2a/T--Aix-Marseille--BenzylAlcohol_pathway.png
 
Figure 1 Metabolic pathway to produce benzyl alcohol
 
Figure 1 Metabolic pathway to produce benzyl alcohol
 
  
 
===Production===
 
===Production===
Line 22: Line 21:
 
Figure 2 SDS-PAGE of HmaS production with induction (2, 3 and) 4, without induction ( 1,NI) and with empty plasmid (5)
 
Figure 2 SDS-PAGE of HmaS production with induction (2, 3 and) 4, without induction ( 1,NI) and with empty plasmid (5)
  
We see overproduction of HmaS of approximatively 37kDa, that's correspond to molecular wheigt of HmaS. Nonetheless, our inducible promotor is not perfect, and there is basal production of HmaS. Moreover negative control is correct, there is noprodution of HmaS with empty plasmid
+
We see overproduction of a protein of approximatively 37kDa, which is consistent with HmaS's molecular weight.  
 +
Nevertheless, our inducible promotor is not perfect, and there is basal production of HmaS (line 1).  
 +
However, negative control is as expected, there is no prodution of HmaS with empty plasmid (line 5).
 +
 
 
===Purification===
 
===Purification===
  
We tried to purify Hmas with Akta pure (GE healthcare) by [https://www.gelifesciences.com/en/us/shop/chromatography/prepacked-columns/size-exclusion/superdex-200-increase-small-scale-size-exclusion-chromatography-columns-p-06190 ion exchange column].After HmaS production , we break ours cells, and with lysate we purify. We used like buffer We used to eluate 60mL of Tampon B (1M NaCl and Tris 20mM) with gradient of 0 to 100%, figure 3.
+
We tried to purify Hmas with Akta pure (FPLC) (GE healthcare) by [https://www.gelifesciences.com/en/si/shop/chromatography/prepacked-columns/ion-exchange/mono-q-anion-exchange-chromatography-column-p-00608#overview ion exchange chromatography] using an anion exchange column. For protocol, see our [http://2018.igem.org/Team:Aix-Marseille/Protocols#Protein_purification wiki]
  
 
https://static.igem.org/mediawiki/parts/4/44/--Aix-Marseille--HmaS_akta_registry.jpg
 
https://static.igem.org/mediawiki/parts/4/44/--Aix-Marseille--HmaS_akta_registry.jpg
  
Figure 3 Elution of HmaS after purification by ion exchange column performed by Akta
+
Figure 3 Elution profile of HmaS during purification by ion exchange column performed by Akta
  
We can see 3 spikes in the elution graph because ion exchange chromatography is not a perfect technique to isolate protein. So we decided to do SDS-PAGE to see if we have our protein (figures 4a and 4b)
+
We can see 3 peaks in the elution profile because ion exchange chromatography is not a specific affinity technique to isolate protein. So we decided to check our protein purification using SDS-PAGE (figures 4a and 4b)
  
 
https://static.igem.org/mediawiki/parts/3/3f/--Aix-Marseille--HmaS_4a_registry.jpg  
 
https://static.igem.org/mediawiki/parts/3/3f/--Aix-Marseille--HmaS_4a_registry.jpg  
  
Figure 4a SDS-PAGE of eluate after purifiction L. Ladder , 1'Bacterial lysate ; 2'pellet of bacteria lysate ; 3' non purified fraction ; 4' breakthrought during protein injection ; 5' breakthrought during wash before elution ; 3,8,9 and 10 elution samples  
+
Figure 4a SDS-PAGE of the eluate after purifiction L. Ladder ; 1'Bacterial lysate ; 2'pellet of bacteria lysate ; 3' non purified fraction ; 4' flow through during protein injection ; 5' flow through during wash before elution ; 3,8,9 and 10 elution samples  
 
https://static.igem.org/mediawiki/parts/f/f8/--Aix-Marseille--HmaS_4b_registry.jpg
 
https://static.igem.org/mediawiki/parts/f/f8/--Aix-Marseille--HmaS_4b_registry.jpg
  
Figure 4b SDS-PAGE of eluate after purifiction L. Ladder 11 to 24 elution sample
+
Figure 4b SDS-PAGE of eluate after purification L. Ladder ; 11 to 24 elution sample
  
We can see a big spot at approxomatively 37kDa, that's may correspond to HmaS. Nevertheless samples are not pure, others proteins are with HmaS. HmaS is on fractions 8 to 17, that's correspon to second spike on figure 3. So w have partly purifed HmaS. However, We can improve this purification, by using other methods like size eclusion chromatography.Bu
+
We can see a major protein at approxomatively 37kDa, this probably corresponds to HmaS.  
 +
Nevertheless, the samples are not pure and contain others proteins in adition to HmaS. HmaS is on fractions 8 to 17, that's correspond to second spike on figure 3. This data show that we managed to produce and purify HmaS,while the purification step could be improved, for example using size exclusion chromatography.
  
 
===Activity test===
 
===Activity test===
  
We mesure (S)Mandelate production by HPLC. To prepare sample for HPLC, after ON production of HmaS (LB, glucose 20 g/L, indution OD 0.8 with 1mM IPTG, at 30°C.Centrifugation, and washing the pellet with PBS 1X pH7. Resupend te pellet with PBS 1X (pH7), glucose (5 g/L), phenylpyruvate (0,5 g/L) and begin the measurements with HPLC with C18 column with supernatent of aliquot (1mL) evry hours durinf 7 hours. We test 4 conditions, DH5α, DH5α with empty plasmid, DH5α pSB1A2_BBa K2718011, DH5α pSB1C3_BBa K2718011.
+
We mesured (S)Mandelate production by HPLC. For the protocol see [ here]. We tested 3 conditions, DH5α with empty an plasmid, DH5α pSB1A2_BBa K2718011, DH5α pSB1C3_BBa K2718011.
 +
 
 +
https://static.igem.org/mediawiki/2018/2/25/T--Aix-Marseille--Hplc_s_mandelate_rate_evolution_new.png
 +
 
 +
Figure 5 Measurements of (S)Mandelate production by HPLC
 +
 
 +
The first thing that can be noticed is the global increase in (S) mandelate concentrations. There is some mandelate production in the control strain possibly due to non-enzymatic degradation of the phenyl-pyruvate. We can conclude that there seems to be a (S) mandelate synthase activity, as the (S) mandelate rate are highter in our transformed strain than the E.coli strain with empty plasmid (in particular with the psb1c3 plamsid).In addition, the HPLC peak separation is not perfect, so a modification of the gradient parameters between solution A and B, as well as elution time, might improve the results. For more detailled results, visit our [http://2018.igem.org/Team:Aix-Marseille/Experiments#Mandelate_synthase_activity wiki]
  
 
=== Design notes===
 
=== Design notes===
Line 64: Line 73:
 
<partinfo>BBa_K2718011 parameters</partinfo>
 
<partinfo>BBa_K2718011 parameters</partinfo>
 
<!-- -->
 
<!-- -->
 +
===Sources===
 +
 +
Pugh, S., McKenna, R., Halloum, I., and Nielsen, D. R. (2015). EngineeringEscherichia coli for renewable benzyl alcohol production. Met. Eng. Commun.2, 39–45. doi: 10.1016/j.meteno.2015.06.002

Latest revision as of 23:45, 17 October 2018


IPTG inductible promotor RBS (strong) HmaS

Usage and Biology

HmaS is the first enzyme in the metabolic pathway shown in figure 1 used to produce benzaldehyde and benzyl alcohol. HmaS catalyzes the oxidative decarboxylation of phenylpyruvate to produce(S)Mandelate.


T--Aix-Marseille--BenzylAlcohol_pathway.png Figure 1 Metabolic pathway to produce benzyl alcohol

Production

We producted HmaS in E.coli DH5alpha, with 1mm IPTG at OD 0.8, 3 hours

T--Aix-Marseille--HmaS_product_registry.jpg

Figure 2 SDS-PAGE of HmaS production with induction (2, 3 and) 4, without induction ( 1,NI) and with empty plasmid (5)

We see overproduction of a protein of approximatively 37kDa, which is consistent with HmaS's molecular weight. Nevertheless, our inducible promotor is not perfect, and there is basal production of HmaS (line 1). However, negative control is as expected, there is no prodution of HmaS with empty plasmid (line 5).

Purification

We tried to purify Hmas with Akta pure (FPLC) (GE healthcare) by ion exchange chromatography using an anion exchange column. For protocol, see our [http://2018.igem.org/Team:Aix-Marseille/Protocols#Protein_purification wiki]

--Aix-Marseille--HmaS_akta_registry.jpg

Figure 3 Elution profile of HmaS during purification by ion exchange column performed by Akta

We can see 3 peaks in the elution profile because ion exchange chromatography is not a specific affinity technique to isolate protein. So we decided to check our protein purification using SDS-PAGE (figures 4a and 4b)

--Aix-Marseille--HmaS_4a_registry.jpg

Figure 4a SDS-PAGE of the eluate after purifiction L. Ladder ; 1'Bacterial lysate ; 2'pellet of bacteria lysate ; 3' non purified fraction ; 4' flow through during protein injection ; 5' flow through during wash before elution ; 3,8,9 and 10 elution samples --Aix-Marseille--HmaS_4b_registry.jpg

Figure 4b SDS-PAGE of eluate after purification L. Ladder ; 11 to 24 elution sample

We can see a major protein at approxomatively 37kDa, this probably corresponds to HmaS. Nevertheless, the samples are not pure and contain others proteins in adition to HmaS. HmaS is on fractions 8 to 17, that's correspond to second spike on figure 3. This data show that we managed to produce and purify HmaS,while the purification step could be improved, for example using size exclusion chromatography.

Activity test

We mesured (S)Mandelate production by HPLC. For the protocol see [ here]. We tested 3 conditions, DH5α with empty an plasmid, DH5α pSB1A2_BBa K2718011, DH5α pSB1C3_BBa K2718011.

T--Aix-Marseille--Hplc_s_mandelate_rate_evolution_new.png

Figure 5 Measurements of (S)Mandelate production by HPLC

The first thing that can be noticed is the global increase in (S) mandelate concentrations. There is some mandelate production in the control strain possibly due to non-enzymatic degradation of the phenyl-pyruvate. We can conclude that there seems to be a (S) mandelate synthase activity, as the (S) mandelate rate are highter in our transformed strain than the E.coli strain with empty plasmid (in particular with the psb1c3 plamsid).In addition, the HPLC peak separation is not perfect, so a modification of the gradient parameters between solution A and B, as well as elution time, might improve the results. For more detailled results, visit our [http://2018.igem.org/Team:Aix-Marseille/Experiments#Mandelate_synthase_activity wiki]

Design notes

It's a part whith BBa_B0030 like RBS and BBa_R0011 like inducible promotor And coding sequence comes from Amycolatopsis orientalis. And the sequence is optimized for E.coli thanks to IDT tool

This biobrick exists without promotor BBa_K2718010


Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    INCOMPATIBLE WITH RFC[21]
    Illegal BglII site found at 607
    Illegal BamHI site found at 716
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    INCOMPATIBLE WITH RFC[1000]
    Illegal BsaI.rc site found at 556


Sources

Pugh, S., McKenna, R., Halloum, I., and Nielsen, D. R. (2015). EngineeringEscherichia coli for renewable benzyl alcohol production. Met. Eng. Commun.2, 39–45. doi: 10.1016/j.meteno.2015.06.002